Lista de obras - Roberto Ria - Dominio Público Uruguay

90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma

artículo científico publicado en 2011

A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.

artículo científico publicado en 2014

A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.

artículo científico publicado en 2004

A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis: A case report ⬇️

scientific article published on 01 September 2018

A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma

artículo científico publicado en 2003

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

artículo científico publicado en 2013

Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma

artículo científico publicado en 2002

An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis

artículo científico publicado en 2000

Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

scientific article published on 01 January 2000

Angiogenesis and progression in human melanoma.

artículo científico publicado en 2010

Angiogenesis and tumor progression in melanoma

artículo científico publicado en 2000

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas

artículo científico publicado en 2002

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

artículo científico publicado en 1999

Angiogenesis in multiple myeloma

artículo científico publicado en 2013

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients

artículo científico publicado en 2020

Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling

artículo científico publicado en 2009

Antiangiogenesis is produced by nontoxic doses of vinblastine

scientific article published on 01 December 1999

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

scientific article published on 31 January 2011

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

artículo científico publicado en 2016

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

artículo científico publicado en 2016

Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts

artículo científico publicado en 2002

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma

scientific article published on 17 January 2020

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

artículo científico publicado en 1999

Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma.

artículo científico publicado en 2001

Bone marrow angiogenesis and progression in multiple myeloma

artículo científico publicado en 2011

Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells

artículo científico publicado en 2005

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.

artículo científico publicado en 2013

Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma

artículo científico publicado en 1999

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma

artículo científico publicado en 2020

Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma

artículo científico publicado en 2009

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

scientific article published on 18 May 2020

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

artículo científico publicado en 2010

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival

artículo científico publicado en 2014

Can a decreasing ultrafiltration profile affect the dialytic dose administered?

scientific article published on 01 October 2006

Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.

artículo científico

Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity.

artículo científico publicado en 2005

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

artículo científico publicado en 2015

Circulating miRNA markers show promise as new prognosticators for multiple myeloma

artículo científico publicado en 2014

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

artículo científico publicado en 2011

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

scientific article published on 14 September 2018

Could multiple myeloma VEGF modify the systemic microcirculation?

artículo científico publicado en 2012

Delayed complete remission in a patient with multiple myeloma

artículo científico publicado en 2008

Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing

artículo científico publicado en 2015

Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.

artículo científico publicado en 2005

Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells

artículo científico publicado en 2018

Docetaxel versus paclitaxel for antiangiogenesis

artículo científico publicado en 2002

Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?

artículo científico publicado en 2006

Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea

artículo científico publicado en 2015

Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia

artículo científico publicado en 2010

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

artículo científico publicado en 2010

Endothelial cells in the bone marrow of patients with multiple myeloma

artículo científico publicado en 2003

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

scientific article published on 01 March 2008

Erythropoietin as an angiogenic factor in gastric carcinoma

artículo científico publicado en 2003

Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma

artículo científico publicado en 2013

Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation.

artículo científico publicado en 2013

Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation.

artículo científico publicado en 2016

Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies

artículo científico publicado en 2014

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

scientific article published on 03 October 2011

Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies

artículo científico publicado en 2016

Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma

artículo científico publicado en 2019

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.

artículo científico publicado en 2009

Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma

artículo científico publicado en 2016

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target

artículo científico publicado en 2013

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

artículo científico publicado en 2015

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update

artículo científico publicado en 2018

High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment

scientific article published on 09 July 2019

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

artículo científico publicado en 2012

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma

artículo científico publicado en 2011

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?

artículo científico publicado en 2018

Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo

artículo científico publicado en 1999

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

artículo científico publicado en 1998

Identify multiple myeloma stem cells: Utopia?

artículo científico publicado en 2015

In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane

artículo científico publicado en 2003

Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.

artículo científico publicado en 2006

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

artículo científico publicado en 2018

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

artículo científico publicado en 2018

Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers?

artículo científico publicado en 2006

Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells

scientific article published on 11 September 2020

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

artículo científico publicado en 2016

Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.

artículo científico publicado en 2011

Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women

artículo científico publicado en 2006

Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

scientific article published on 01 May 2007

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis

scientific article published on 19 April 2018

Managing myelodysplastic symptoms in elderly patients.

artículo científico publicado en 2009

Mast cell contribution to angiogenesis related to tumour progression.

artículo científico publicado en 2004

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

scientific article published on 09 January 2020

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

artículo científico publicado en 2009

Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma

artículo científico publicado en 2004

Metronomic chemotherapy from rationale to clinical studies: a dream or reality?

artículo científico

Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma

artículo científico publicado en 2001

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

artículo científico publicado en 2015

Monoclonal gammopathy as a marker of primary cerebral lymphoma

artículo científico publicado en 2009

Multiple myeloma macrophages: pivotal players in the tumor microenvironment.

artículo científico publicado en 2013

Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma

artículo científico publicado en 2003

Neutropenia and G-CSF in lymphoproliferative diseases

artículo científico publicado en 2012

Novel agents and new therapeutic approaches for treatment of multiple myeloma.

artículo científico publicado en 2014

Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.

artículo científico publicado en 2013

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

artículo científico publicado en 2008

Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.

artículo científico publicado en 2015

Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients

artículo científico publicado en 2012

Preparation and characterization of novel gellan gum hydrogels suitable for modified drug release.

artículo científico publicado en 2009

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

scientific article published on 09 January 2019

Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9

scientific article published on 01 September 1997

Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression

artículo científico publicado en 2000

Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis

artículo científico publicado en 2006

Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study

artículo científico publicado en 2020

Role of basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study

artículo científico publicado en 1998

Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients

scientific article published on 22 February 2016

Role of hematopoietic growth factors in angiogenesis.

artículo científico publicado en 2001

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment

scientific article published on 27 September 2011

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma

artículo científico publicado en 2002

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers

artículo científico publicado en 2011

Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy

artículo científico publicado en 2004

Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas

artículo científico publicado en 2008

Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss

artículo científico publicado en 2008

Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia.

artículo científico publicado en 2017

Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

artículo científico publicado en 2018

Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane

artículo científico publicado en 1998

TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically

artículo científico publicado en 2000

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response

artículo científico publicado en 2018

Vascular endothelial growth factor and its receptors in multiple myeloma.

artículo científico publicado en 2003

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

artículo científico publicado en 2007

alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.

artículo científico publicado en 2001

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

artículo científico publicado en 2014

Lista de obras de Roberto Ria

90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma

A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.

A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.

A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis: A case report ⬇️

A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma

An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis

Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

Angiogenesis and progression in human melanoma.

Angiogenesis and tumor progression in melanoma

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

Angiogenesis in multiple myeloma

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients

Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling

Antiangiogenesis is produced by nontoxic doses of vinblastine

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma.

Bone marrow angiogenesis and progression in multiple myeloma

Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.

Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma

Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival

Can a decreasing ultrafiltration profile affect the dialytic dose administered?

Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.

Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity.

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

Circulating miRNA markers show promise as new prognosticators for multiple myeloma

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

Could multiple myeloma VEGF modify the systemic microcirculation?

Delayed complete remission in a patient with multiple myeloma

Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing

Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.

Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells

Docetaxel versus paclitaxel for antiangiogenesis

Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?

Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea

Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

Endothelial cells in the bone marrow of patients with multiple myeloma

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

Erythropoietin as an angiogenic factor in gastric carcinoma

Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma

Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation.

Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation.

Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies

Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.

Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update

High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?

Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

Identify multiple myeloma stem cells: Utopia?

In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane

Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers?

Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.